Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-08-28Clinical Trial Update: Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance During the QbTest [Phase 4]
Phase 4 trial investigating how expectation, medication, and placebo influence objective and self-rated performance on the QbTest in ADHD pa…
-
CLINICAL_TRIALS trial_result · 2018-08-15Clinical Trial Update: Melatonin as Adjuvant Treatment for ADHD in Adults [Phase 3]
Phase 3 clinical trial investigating melatonin as an adjuvant treatment for attention deficit hyperactivity disorder in adults.
-
FDA approval · 2018-08-08FDA Approved: JORNAY PM EXTENDED-RELEASE — Original Application (Ironshore Pharmaceuticals Inc.)
FDA approved Jornay PM Extended-Release (methylphenidate hydrochloride) under an original NDA by Ironshore Pharmaceuticals for the treatment…
-
CLINICAL_TRIALS research · 2018-07-31Clinical Trial Update: Cognitive Behavioral Therapy for Adolescents With Attention-Deficit / Hyperactivity Disorder [Phase 4]
This document provides an update on a Phase 4 clinical trial evaluating cognitive behavioral therapy for adolescents with Attention-Deficit/…
-
CLINICAL_TRIALS trial_result · 2018-07-31Clinical Trial Update: Skills Training for Adolescents With ADHD [NA]
The study completed and results were posted for a skills-training program targeting adolescents with ADHD, sponsored by Massachusetts Genera…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2018-07-26Clinical Trial Update: Descriptive Epidemiology of a Specialized Consultation on ADHD in Adults at the Strasbourg University Hospital
Describes a descriptive epidemiology study of a specialized ADHD in adults consultation at Strasbourg University Hospital.
-
FDA approval · 2018-07-25FDA Approved: GUANFACINE EXTENDED-RELEASE — Original Application (Apotex Corp.)
FDA approved Guanfacine Extended-Release from Apotex Corp. as an original application generic. Guanfacine extended-release is used to treat …
-
CLINICAL_TRIALS trial_result · 2018-07-20Clinical Trial Update: Amiloride Hydrochloride as an Effective Treatment for ADHD [EARLY_Phase 1]
An early-phase (Phase 1) trial evaluating amiloride hydrochloride for attention-deficit/hyperactivity disorder was terminated, with results …
-
CLINICAL_TRIALS trial_result · 2018-07-17Clinical Trial Update: Effectiveness of a Tailored Occupational Therapy Intervention for Women With ADHD [NA]
This clinical trial update reports on the effectiveness of a tailored occupational therapy intervention for women with Attention Deficit Hyp…
-
FDA approval · 2018-07-16FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE — Supplemental Application (Prasco Laboratories)
The FDA has approved a supplemental application from Prasco Laboratories for a mixed salt formulation of dextroamphetamine and amphetamine (…
-
CLINICAL_TRIALS research · 2018-07-13Clinical Trial Update: A Study of Identity Building in Children With ADHD [NA]
This clinical trial update describes a study on identity-building in children with ADHD, sponsored by University Hospital, Caen; no current …
-
CLINICAL_TRIALS withdrawal · 2018-07-13Clinical Trial Update: Improving the Medication Management of Patients With Attention-Deficit Hyperactivity Disorder [NA]
A clinical trial evaluating medication management for Attention-deficit/hyperactivity disorder has been withdrawn. The study identified as N…
-
CLINICAL_TRIALS trial_result · 2018-07-11Clinical Trial Update: Comparison of Treadmill and Whole Body Vibration Training in Children With Attention Deficit Hyperactivity Disorder [NA]
This clinical trial compared treadmill training to whole-body vibration training in children with Attention Deficit Hyperactivity Disorder a…
-
CLINICAL_TRIALS research · 2018-07-11Clinical Trial Update: International Study to Predict Optimised Treatment in Attention Deficit/Hyperactivity Disorder [Phase 4]
An international Phase 4 study update focusing on predicting optimized treatment strategies for Attention Deficit/Hyperactivity Disorder.
-
CLINICAL_TRIALS trial_result · 2018-06-20Clinical Trial Update: Single-dose Potassium Supplementation in Patients With ADHD for Whom the Anesthetic Lidocaine is Ineffective [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating the effect of a single-dose potassium supplement in patients with ADHD who do not respond to lidoca…
-
CLINICAL_TRIALS trial_result · 2018-06-20Clinical Trial Update: Effectiveness of Collaborative Tele-Mental Health Services for ADHD in Primary Care [NA]
This clinical trial update assesses the effectiveness of collaborative tele-mental health services for attention-deficit/hyperactivity disor…
-
CLINICAL_TRIALS trial_result · 2018-06-18Clinical Trial Update: Control of Cognition (Naltrexone, Methylphenidate, and ADHD Study (NMAS)) [Phase 4]
Phase 4 clinical trial evaluating the combination of naltrexone and methylphenidate for cognition in healthy individuals and in Attention De…
-
CLINICAL_TRIALS trial_result · 2018-06-15Clinical Trial Update: Metabolic Effects of Antipsychotics in Children [Phase 4]
Phase 4 pediatric trial evaluating the metabolic effects of antipsychotics; results have been posted following completion.
-
CLINICAL_TRIALS trial_result · 2018-06-15Clinical Trial Update: Omega-3 Polyunsaturated Fatty Acids in Youth With ADHD [NA]
The clinical trial evaluating omega-3 polyunsaturated fatty acids in youth with ADHD has completed.
-
CLINICAL_TRIALS trial_result · 2018-06-14Clinical Trial Update: Evaluating the Methylphenidate Patch to Treat Former Stimulant Users With ADHD [NA]
A clinical trial update reports results from evaluating a methylphenidate transdermal patch for adults with attention-deficit/hyperactivity …
-
CLINICAL_TRIALS trial_result · 2018-06-12Clinical Trial Update: Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders [Phase 1]
Phase 1 trial update evaluating pharmacokinetics, safety, and tolerability of oral brexpiprazole in children 6 to <13 with CNS disorders; st…
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children [Phase 4]
A Phase 4 clinical trial comparing stimulant versus nonstimulant medications for Attention-deficit/hyperactivity disorder in children has co…
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: Neurobiological Basis of Response to Vyvanse in Adults With ADHD: an fMRI Study of Brain Activation [Phase 4]
Phase 4 study using fMRI to explore brain activation and neurobiological predictors of response to lisdexamfetamine in adults with ADHD; res…
-
CLINICAL_TRIALS research · 2018-06-06Clinical Trial Update: Oculometry as an Attentional Mechanism Evaluation Tool and Attention Deficit Hyperactivity Inhibition [NA]
This entry describes a University Hospital, Grenoble clinical trial evaluating oculometry as an attentional mechanism assessment tool and it…
-
CLINICAL_TRIALS trial_result · 2018-05-31Clinical Trial Update: Effects of Structured Skills Training Group in Treatment of ADHD in Adults [NA]
A completed clinical trial evaluating structured skills training for adults with attention-deficit/hyperactivity disorder (ADHD).